{"transactions":[{"id":747787,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:45:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 and (2) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8000,"derivative":{"exercise_price":24.11,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-259808","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259808/ownership.xml","form_type":"4"}},{"id":1117772,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:14.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":3500,"derivative":{"exercise_price":15.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-083700","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083700/ownership.xml","form_type":"4"}},{"id":1497761,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T20:15:06.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":2750,"derivative":{"exercise_price":15.06,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-24-066606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024066606/ownership.xml","form_type":"4"}},{"id":1874684,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T20:25:10.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 25, 2024 and (2) the date of the Issuer's 2024 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":0.972,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-032884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919123032884/doc4.xml","form_type":"4"}},{"id":1915516,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-04-21T20:55:25.000Z","date":"2023-04-19","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity\nIncentive Plan (the \"Plan\")) and accelerated on the closing of a Change of Control (as defined in the Plan)."}],"balance_after":18000,"derivative":{"exercise_price":1.82,"expiration_date":"2033-04-18","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-23-025288","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919123025288/doc4.xml","form_type":"4"}},{"id":2229610,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-16T21:11:34.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the \"Plan\")) and accelerated on the closing of a Change of Control (as defined in the Plan)."}],"balance_after":15750,"derivative":{"exercise_price":1.3,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001209191-22-037670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122037670/doc4.xml","form_type":"4"}},{"id":2253233,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-27T20:36:09.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 25, 2023 and (2) the date of the Issuer's 2023 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":1.69,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-032572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919122032572/doc4.xml","form_type":"4"}},{"id":2655587,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-06-24T19:01:32.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders."}],"balance_after":10500,"derivative":{"exercise_price":6.55,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-21-043143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919121043143/doc4.xml","form_type":"4"}},{"id":2698718,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-24T21:01:25.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest in three equal installments, assuming continuous service on each vesting date, as follows: May 20, 2022; May 20, 2023; and May 20, 2024."}],"balance_after":30000,"derivative":{"exercise_price":4.03,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-035400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919121035400/doc4.xml","form_type":"4"}},{"id":2802655,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-08T16:50:03.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the stock option shall vest on each anniversary of the grant date identified in Column 3 above."}],"balance_after":21000,"derivative":{"exercise_price":8.93,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-21-018582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919121018582/doc4.xml","form_type":"4"}}]}